BioStock: Iconovo closed the books on 2020 with good turnover

23 February 2021 - 10:37

Last week, Iconovo published its report for the fourth quarter and the result for the full year 2020. The company reported a higher turnover compared with the previous year, which is mainly due to the fact that Iconovo achieved several sub-goals within the customer projects. During the past year, Iconovo also initiated new projects with strong partners.

Read the full article at

This is a press release from BioStock - Connecting Innovation & Capital.

Provided by: Cision
Nasdaq First North GM (Sweden)
Iconovo AB
Iconovo AB is engaged in developing proprietary inhalation products for licensing to customers. The company offers ICOres, ICOone, ICOcap, and ICOpre devices....
Learn more about company

Related news

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date